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OBJECTIVES: Chronic kidney disease is a major public health problem worldwide. In Brazil, approximately
100,000 patients (January 2012) receive renal replacement therapy. Nevertheless, data on dialysis incidence in
the Brazilian population are scarce. This study aims to analyze the incidence of patients starting dialysis therapy
in Sa˜o Paulo City, the largest Brazilian metropolis.
METHOD: This cohort study analyzed data from 9,994 patients starting hemodialysis or peritoneal dialysis
funded by the Brazilian Public Health System during a 5-year period (2007–2011). Patient data for this study
(recorded as electronic files) were obtained from the Sa˜o Paulo City’s Dialysis Regulatory Bureau, which
regulates the allocation of patients requiring dialytic therapy.
RESULTS: The dialysis incidence rates were 178, 174, 170, 185 and 188 per million population for the years 2007,
2008, 2009, 2010 and 2011, respectively. The incidence rates increased with age. Hypertension and diabetes
were the main etiologies diagnosed. Hemodialysis was the chosen dialysis modality in the majority of patients
(92.6%), whereas the percentage of patients referred for peritoneal dialysis decreased from 10.1% to 5.5%.
CONCLUSION: The incidence of patients starting renal replacement therapy from 2007–2011 in Sa˜o Paulo was
stable but higher than the projected incidence for the entire country. The authors emphasize the need for
further studies of the incidence of dialysis in the Brazilian population and for the creation of a Brazilian registry
of dialysis patients, which would be a valuable tool for developing healthcare policies and renal replacement
therapy strategies.
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& INTRODUCTION
Chronic kidney disease (CKD) is characterized by a
progressive decline in renal function; it is currently
classified into 5 stages based on the presence of kidney
damage and/or the reduced estimated glomerular filtration
rate (1). CKD stage 5, which is defined as a glomerular
filtration rate of ,15 ml/min/1.73 m2 and also known as
end-stage renal disease (ESRD), reflects a kidney failure
stage in which most patients will require renal replacement
therapy ([RRT], i.e., dialysis or kidney transplantation) to
sustain life. Both RRT modalities are associated with
significant morbidity and mortality risks and represent
major health care costs. Thus, worldwide, CKD is consid-
ered a major public health problem that contributes to the
global burden of noncommunicable diseases (2).
Worldwide, more than 2 million patients require RRT; the
majority are located in the United States of America (USA),
where nearly 0.5 million patients are treated with dialysis or
transplantation for kidney failure (3). During the last 2
decades, the annual growth in the number of dialysis
patients was 6-12% in many developed countries, and the
growth rate in several developing countries was even higher
(2). However, even this growth rate likely represents far less
than the actual need for RRT (4) because in many countries,
particularly in developing countries, there is a large number
of undiagnosed CKD patients, and access to RRT remains
unaffordable for some members of the affected population
(2-5). Thus, CKD has often been described as a rising global
epidemic (6). In fact, many reports have described the rising
prevalence of CKD in the general population. However,
recent data point toward a slight reduction in the CKD
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prevalence in South Korea (7), and the incidence rates of
patients starting RRT have been reported as decreasing in
the USA in recent years (8,9) and stabilizing in Europe (10).
Brazil is the fifth-largest country in the world, both by
population (192.3 million inhabitants in 2011) and area
(8,514,877 km2). Brazil has the third-largest dialysis popula-
tion worldwide, and together with the USA, Japan, Italy and
Germany, it accounts for 56% of all RRT patients (3,11).
In January 2012, there were 91,314 patients undergoing
dialysis in Brazil, the majority of whom (,85%) were being
funded by the Brazilian Public Health System (BPHS) (12).
The dialysis prevalence in Brazil was estimated as 475
dialysis patients per million of population (pmp) (12).
Although information regarding the prevalence of patients
undergoing dialysis in Brazil is readily available, data on
dialysis incidence are scarce and based on projections
(13,14). In the present study, we aimed to evaluate the
incidence of patients starting dialysis therapy in Sa˜o Paulo
City, the largest Brazilian metropolis, during a 5-year period
(2007–2011) and also to compare it with the incidences
projected for countries with equivalent populations.
& PATIENTS AND METHODS
This cohort study analyzed the data from patients starting
hemodialysis or peritoneal dialysis from January 1st, 2007 to
December 31st, 2011, who were referred from the Sa˜o Paulo
City Dialysis Regulatory Bureau (SPc-DRB). SPc-DRB,
which is funded by the BPHS, is a division of Sa˜o Paulo
City’s Health Bureau, which regulates the allocation of
patients with ESRD requiring dialytic therapy into 36
satellite dialysis centers. Note that the present analysis
was limited to the patients receiving dialytic therapy that
was supported by the public health system (approximately
85% in Brazil). In Sa˜o Paulo City, when a physician refers a
patient to start a chronic program of hemodialysis or
peritoneal dialysis funded by the BPHS, a specific ques-
tionnaire must be completed and sent to the SPc-DRB. The
patients are identified by name, mother’s name, birth date,
BPHS number and address. In addition to the data
identification, the questionnaire comprises information
about the presumptive diagnosis, previous dialytic treat-
ment and/or kidney transplantation, hepatitis B (HBV),
hepatitis C (HCV), and HIV serology, as well as the
requested RRT modality. After a complete analysis of the
questionnaire, each patient receives a unique SPc-DRB
number before being forwarded to one of the satellite
dialysis units. This protocol procedure allows the SPc-DRB
(funded by the BPHS) to have almost complete control of
the incidence and prevalence of dialysis patients in Sa˜o
Paulo City because the SPc-DRB number is required for
therapy reimbursement. This form began to be recorded in
electronic files in mid-2006, which provided us with the
data for analysis. For the present analysis, we excluded
current dialysis patients and those who had previously
received a kidney transplant; additionally, the data bank
was double-checked to exclude duplicate patients, those
who had been transferred between dialysis units and
patients not living in Sa˜o Paulo City. Note that the patients
with acute kidney injury were not included in the data bank
because their access to dialysis therapy was not regulated by
the SPc-DRB. To compare the dialysis incidence in Sa˜o
Paulo with the incidences projected for other countries, we
used the data available from the US Renal Data System
(USRDS) and the United Nations (15,16).
Statistical analysis
The variables were expressed as median (interquartile
range [IQR]) or as absolute (n) and relative (%) values, as
appropriate. Age- and gender-standardized dialysis annual
incidence rates pmp were calculated on the basis of the
official Sa˜o Paulo City population (17). Standardized
incidence rates were estimated to analyze the variation in
incidence compared to the first year (2007). Gender
comparisons by age strata were made using the Poisson
regression analysis and presented by incidence rate (IR)
with a 95% confidence interval (CI). A p for trend analysis
was conducted to show the variations in patient character-
istics throughout the study period.
Statistical significance was set at the level of p,0.05, and
the statistical analyses were performed using the SPSS
software version 17.0 (SPSS Inc., Chicago, IL, USA) and SAS
version 9.3 (SAS Campus Drive, Cary, NC, USA 27513).
& RESULTS
Dialysis incidence rate
The dialysis incidence rates in the city of Sa˜o Paulo from
2007 to 2011 are shown in Table 1. A total of 1,956 new ESRD
patients started dialysis therapy in 2007, with an adjusted
incidence rate of 178 pmp. Incidence rates in 2008, 2009,
2010 and 2011 were 174, 170, 185 and 188 pmp, respectively.
Using 2007 as a reference, the age- and gender-standardized
incidence rates from 2008, 2009, 2010 and 2011 were, 0.98,
0.96, 1.04 and 1.06, respectively, as shown in Figure 1.
Considering that the Sa˜o Paulo City population is as large
as that of many countries, the results obtained in this study
were compared not only with the incidence rate of ESRD in
Brazil but also with the rates of other countries with similar
populations and with South American countries (Table 2),
as reported by USRDS (15). For the period between 2007 and
2009, the ESRD incident rates in Sa˜o Paulo were maintained
at similar levels (ranging from 178 to 170 pmp), whereas the
reported overall Brazilian dialysis incidence rate during the
same period ranged from 140 to 99 pmp. Note that the
dialysis incidence in the city of Sa˜o Paulo were comparable
with those of Greece, Belgium, and the Czech Republic,
countries with populations similar to that of Sa˜o Paulo city.
However, for the same period, the incidence rates of ESRD
in Sa˜o Paulo were higher than those reported for other
South American countries, such as Argentina, Chile and
Uruguay, but were only half the ESRD rate in the USA.
Table 1 - Incidence of patients starting dialysis in Sa˜o
Paulo from 2007–2011.
Year
Sa˜o Paulo City
population* Incidence
Absolute ‘‘n’’
Per million
population
2007 11,019,484 1,956 178
2008 11,093,746 1,927 174
2009 11,168,194 1,897 170
2010 11,245,983 2,080 185
2011 11,337,021 2,134 188
*Data available at http://www.seade.gov.br/produtos/projpop/(17).
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Characteristics of patients starting dialytic therapy
The clinical characteristics of this population are shown in
Table 3. From 2007 to 2011, 9,994 patients (median age, 59
years, IQR, 47–70 years) started dialysis in Sa˜o Paulo; the
majority of patients were males (58.7%). The age-specific
incidences, which increased steadily with age, for males and
females are shown in Figures 2A and 2B. Using individuals
younger than 20 years as the reference point, the rate for
starting dialysis was 8.16 (95% CI, 7.29–9.12) times higher
for patients aged between 20 and 44 years, 36.08 (95% CI,
32.34–40.25) times higher for patients aged between 45 and
64 years, 77.62 (95% CI, 69.41–86.79) times higher for
persons aged between 65 and 74 years and 98.99 (95% CI,
88.45–110.79) times higher for those aged 75 years or older.
Males had a higher dialysis incidence than women (IR: 1.87.
95% CI: 1.82–1.93) (Figure 3).
Overall, diabetes (23.1%) and hypertension (15.5%)
accounted for most of the main presumptive diagnoses of
CKD requiring RRT in Sa˜o Paulo City during the study
period, representing approximately 39% of all cases. Note
that the majority of patients were referred without a known
etiology. The CKD etiologies did not change significantly
over the study period (Table 3).
Hemodialysis was the dialysis modality of choice,
showing a significant increase over the last 5 years. The
percentage of patients referred for peritoneal dialysis
decreased from 10.1% in 2007 to 5.5% in 2011.
Incidence rates of hepatitis B, hepatitis C and anti-
HIV seropositivity in dialysis patients
The incidence of patients with positive serology for the
HBV as well as HIV increased gradually during the study
period, whereas the incidence of HCV remained stable
(Table 3).
& DISCUSSION
The present study analyzed the incidence of patients
starting chronic dialysis therapy in Sa˜o Paulo City from 2007
to 2011. The data for this analysis was obtained from the data
bank of a government agency that regulates the allocation of
patients with ESRD requiring dialysis therapy, which was
funded by the BPHS. In Brazil, the BPHS is responsible for
supporting the majority of patients maintained on chronic
dialysis therapy, approximately 85% of all patients; the
remaining 15% of patients are supported by private health
insurance companies (12). It is remarkable that the data
presented here are not based on projections but are the
result of the reliable analysis of concrete data on the
incidence of chronic dialysis supported by the government
in Sa˜o Paulo City.
The dialysis incidence in Sa˜o Paulo (i.e., 170-188 pmp for
the study period) was higher than that estimated for the
entire Brazilian population. According to the Brazilian
Dialysis Census 2009, the incidence of patients on dialysis
was estimated to be 144 pmp (18), and USRDS projections
showed an even lower figure (99 pmp) (15), whereas the
incidence rate in Sa˜o Paulo (according to the current study)
was higher, 170 pmp. One possible explanation for these
disparities may be related to the method employed for
calculating the incidence. The rates reported by the Brazilian
Dialysis Census were based on a questionnaire, completed
online by the dialysis centers, which has a response rate of
approximately 70% (12); thus, the incidences were calcu-
lated based on estimates that could have been inaccurate.
Alternatively, this discrepancy might have been the result
of geographic and socioeconomic disparities among the
different regions in Brazil. As recently reported by
Couchoud et al. (19), in the French population, socio-
economic background and the medical practices related to
public health system may explain substantial between-area
variations in CKD patients access to renal replacement
therapy. According to the Brazilian Dialysis Census 2011
(12), the dialysis incidence for the southwest region, in
which Sa˜o Paulo is located, was nearly identical to the rate
presented here. However, one important observation of our
study is that incidence rates in Sa˜o Paulo were found to be
rather stable during the observation period. The annual
incidence of dialysis initiation varied by only ¡5% as
compared to the 2007 data. This finding is in agreement
with the reported stabilization of European dialysis inci-
dence (10) and even decreasing trends in the USA (8,9).
Our data showed that the incidence of dialysis initiation
in Sa˜o Paulo was comparable to the ESRD/dialysis
incidence rates reported for some European countries with
Table 2 - Demographic and reported incidence rates of
ESRD from 2007–2009: A comparative analysis of Sa˜o
Paulo City with Brazil and other countries.
Population
(million) Incidence of ESRD (pmp)
2010* 2007# 2008# 2009#
Sa˜o Paulo City 11.25 178 174 170
Greece 11.36 192 201 204
Belgium, Dutch
speaking
10.71 190 190 201
Belgium, French
speaking
187 190 196
Czech Republic 10.49 185 182 181
Brazil 194.95 140 148 99
Argentina 40.41 151 144 151
Chile 17.11 144 153 153
Uruguay 3.37 143 166 135
United States 310.38 362 363 371
*Data obtained from the United Nations Statistics Division, available at
http://esa.un.org/unpd/wpp/unpp/panel_population.htm (16).
# Data obtained from USRDS 2011 (http://www.usrds.org) (15).
Figure 1 - Age- and gender-standardized incidence rates ratios
(versus 2007 incidence) for the 2008–2011 period.
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similar populations, such as Greece, Belgium and the Czech
Republic (15). However, the incidence of dialysis initiation
in Sa˜o Paulo was higher than those reported by other South
American countries, but still half the reported incidence rate
in the USA (15). A limitation in this comparison is that our
data did not include incident kidney transplants. However,
in the spite of the large kidney transplantation program in
Brazil—with 4,630 kidney transplants performed in 2010
(24.1 pmp) (20)—particularly in the southwest region
(13,14,20,21), the percentage of preemptive renal transplan-
tation in Brazil is still low. Therefore, the dialysis incidence
most likely equals the ESRD incidence (13,14,20,21). We
should also consider some limitations of the present
analysis, such as that our data collection did not include
patients with dialysis therapy covered by private health
insurance or those who died before being discharged from
the hospitals. Taken together, we may speculate that the
rates presented here underestimate the real dialysis inci-
dence in Sa˜o Paulo City. The lack of national data on CKD
patients to serve as a control, as previously noted (22), limits
our analysis, and thus readers also should note that the
comparisons between the dialysis incidence in Sa˜o Paulo
City and those for Brazil and other countries presented here
are crude and may be not be precise because of the
differences in the compositions of the various populations.
The increased incidence of dialysis in people older than
65 years occurred in parallel with longer life expectancies
for the Brazilian population and with the comorbidities
Figure 2 - Dialysis incidence rate adjusted by age strata in males (A) and females (B).
Table 3 - Demographic and clinical characteristics of patients who started dialysis treatment in Sa˜o Paulo City from
2007–2011.
Year
TOTAL 2007 2008 2009 2010 2011 p for trend
Subjects n= 9,994 n=1,956 n=1,927 n=1,897 n= 2,080 n=2,134
Gender, n (%) 0.574
Male 5,870 (58.7%) 1,146 (58.6%) 1,122 (58.2%) 1,121 (59.1%) 1,210(58.2%) 1,271(59.6%)
Female 4,124 (41.3%) 810 (41.4%) 805 (41.8%) 776(40.9%) 870(41.8%) 863(40.4%)
Age, n (%)
,20 years 168 (1.7%) 30(1.5%) 41 (2.1%) 34(1.8%) 31(1.5%) 32(1.5%)
20–44 years 1,981 (19.8%) 400 (20.4%) 349 (18.1%) 400(21.1%) 396 (19.0%) 436 (20.4%)
45–64 years 4,181 (41.8%) 819 (41.9%) 782(40.6%) 769(40.5%) 935 (45.0%) 876 (41.0%) 0.312
65–74 years 2,002 (20.0%) 369 (18.9%) 409 (21.2%) 364(19.2%) 404 (19.4%) 456 (21.4%)
$75 years 1,662 (16.7%) 338 (17.3%) 346 (18.0%) 330(17.4%) 314 (15.1%) 334 (15.7%)
Etiology of CKD,
n (%)
Diabetes 2,305(23.1%) 465(23.8%) 453 (23.5%) 384(20.2%) 556(26.7%) 447(21.0%) 0.842
Hypertension 1,550(15.5%) 339(17.3%) 326 (16.9%) 272(14.4%) 325(15.6%) 288(13.5%)
Glomerulonephritis 475(4.8%) 120(6.1%) 97 (5.0%) 94(5.0%) 90(4.3%) 74(3.5%)
Polycystic Kidney
Disease
132(1.3%) 19(1.0%) 36 (1.9%) 25(1.3%) 26(1.3%) 26(1.2%)
Unknown 5,320 (53.2%) 954(48.8%) 935 (48.5%) 1,065(56.1%) 1,070(51.5%) 1,296(60.7%)
Dialysis modality,
n (%)
Hemodialysis 9,256 (92.6%) 1,758 (89.9%) 1,776 (92.2%) 1,756(92.6%) 1,950(93.7%) 2,016(94.5%) ,0.001
Peritoneal Dialysis 738 (7.4%) 198 (10.1%) 151 (7.8%) 141(7.4%) 130(6.3%) 118(5.5%)
Chronic Infectious
Diseases, n (%)
HBV 364 (3.6%) 33 (1.7%) 50 (2.6%) 30(1.6%) 119(5.7%) 132(6.2%) 0.039
HCV 463(4.6%) 89 (4.6%) 109 (5.7%) 87(4.6%) 81(3.9%) 97(4.6%)
HIV 305 (3.1%) 26 (1.3%) 24 (1.3%) 30(1.6%) 93(4.5%) 132(6.2%)
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associated with aging (9,23). Our results also show an
important gender difference in dialysis incidence, which is
in agreement with the previously reported faster progres-
sion rate of many renal diseases in males (24-27). This
difference in CKD progression between males and females
may be attributed to a number of factors, including the
differential impact of sex hormones on kidney damage and
also a combination of environmental, socioeconomic, life-
style and health care factors (28).
The cause of the CKD was unknown for the majority of
the patients, as was previously reported for the Brazilian
population (14). This issue may be a consequence of the fact
that the majority of patients initiating RRT in Brazil come
from emergency units at public hospitals, and only a small
proportion of patients had actually seen a nephrologist
before starting dialysis (21). Hemodialysis was the most
common modality of dialysis therapy for the patients
initiating RRT in Sa˜o Paulo, and a clear decreasing trend
in the choice of peritoneal dialysis was observed in our
study. This trend agrees with the data from the USA for the
corresponding time period (15), although recent data
indicates that the number of patients treated with peritoneal
dialysis pmp in both developing and developed countries
has increased over the last decade (29). Among the factors
that may favor the choose of hemodialysis instead of
peritoneal dialysis in Brazil, the economic constraints
undoubtedly have a major impact. With regard this,
although the reimbursement for hemodialysis and perito-
neal dialysis provided by BPHS is approximately the same,
the final income for the owners of dialysis centers is much
lower for peritoneal dialysis, which impacts financial
incentives and the viability of maintaining these programs
(21).
An interesting observation is the progressive increase in
the number of patients with HBV and HIV positive
serology. Of note, the number of individuals infected by
HBV may be overestimated because since 2009, patients
classified as positive were not only those with the surface
antigen (HBsAg positive) but also patients who presented
with anti-HBc positive in the absence of a positive anti-HBs.
In fact, the prevalence of chronic HBV infection in Sa˜o Paulo
City was estimated at 1.02% (30). The observed increase in
the incidence of HIV patients starting dialysis may reflect
the significant improvement in the life expectancies of HIV
patients, which corresponds with access to the highly active
antiretroviral drugs provided to the affected population
through the BPHS (31).
To conclude, the incidence rate of patients starting RRT
from 2007 to 2011 in Sa˜o Paulo (using reliable data on actual
treatments) was higher than the projected incidence for the
entire country of Brazil. Compared with the 2007 data, the
incidence rates were stable from 2008 to 2011. We hope that
the current report will stimulate action toward creating a
Brazilian registry of dialysis patients. Such a registry would
be a valuable tool for the planning, development and
monitoring of national healthcare policies. In particular,
such data would allow for a better understanding of the
factors influencing the temporal trends in the changes in
RRT incidence and prevalence patterns, such as the timing
of dialysis initiation, choice of dialysis modality and clinical
outcomes (morbidity and mortality); these data are crucial
when formulating national strategies for RRT in Brazil.
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